1987
DOI: 10.1016/s0950-3536(87)80035-5
|View full text |Cite
|
Sign up to set email alerts
|

The BCR/ABL hybrid gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0
2

Year Published

1990
1990
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(21 citation statements)
references
References 63 publications
0
19
0
2
Order By: Relevance
“…The same ber-abl provirus insert as in the primary mouse was found in day-14 mixed myeloid spleen VOL. 12,1992 on May 12, 2018 by guest http://mcb.asm.org/ colonies from one secondary recipient of bone marrow cells (5) and in the T-cell leukemia arising in a secondary recipient of bone marrow cells from another mouse with granulocytic disease (6). Since CML is a stem cell disease, multipotential cells may be the only targets in which ber-abl expression leads to a disease with a predominantly myeloid phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…The same ber-abl provirus insert as in the primary mouse was found in day-14 mixed myeloid spleen VOL. 12,1992 on May 12, 2018 by guest http://mcb.asm.org/ colonies from one secondary recipient of bone marrow cells (5) and in the T-cell leukemia arising in a secondary recipient of bone marrow cells from another mouse with granulocytic disease (6). Since CML is a stem cell disease, multipotential cells may be the only targets in which ber-abl expression leads to a disease with a predominantly myeloid phenotype.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, minor BCR, involving a breakpoint between exons 1 and 2 of BCR, encodes a 190-kDa-fusion protein. This latter fusion is observed in 90% of BCR-ABL1-positive pediatric BCP-ALL [92][93][94]. Fusion of the BCR signaling protein with the ABL nonreceptor tyrosine kinase results in a constitutive tyrosine kinase activity, activating multiple signaling pathways, increasing cell proliferation, and deregulating differentiation and adhesion [95].…”
Section: Bcr-abl1mentioning
confidence: 99%
“…16,17 In this translocation, the c-ABL proto-oncogene is transposed from its normal position on chromosome 9 to a 5.8 kb major breakpoint cluster region M-BCR on chromosome 22, forming a BCR-ABL fusion gene. 17,18 The new gene encodes p210 BCR/ABL , an oncoprotein that has increased tyrosine kinase (TK) activity 19,20 and increased binding to the actin cytoskeleton 21 compared with the p145 Abelson protein, both of which contribute to transformation. The presence of p210 BCR/ABL causes growth factor independence and leukemic cell growth in hematopoietic cell lines.…”
Section: Molecular Biology Of Bcr-ablmentioning
confidence: 99%